The COVID-19 vaccine was a triumph of science. Governments, researchers, and vaccine manufacturers worked in tandem to ...

Mayo Clinic researchers and collaborators have shown that artificial intelligence (AI) can analyze routine pathology slides to help classify meningiomas, the most common primary brain tumor ...

Q.ANT successfully demonstrated a diffusion model and a recurrent neural network on its second-generation Native Processing Unit (NPU) at ISC High Performance 2026 in Hamburg. This proves that Q.ANT’s ...

United States (Loudoun County, Virginia; Silicon Valley, California) — Localised stress and recurrent California drought. Water use in Loudoun’s “Data Centre Alley” is up roughly 250 percent since ...

Preclinical trials showed the nanovaccine was effective in eradicating primary HPV-related tumors and metastatic cancer that spread to other organs, with 71% of mice with metastatic lung cancer still ...

BREASTEST Monitor development used over 450 samples; algorithm tested on 100 samples, with 23 recurrences and 77 controls.

BCAL Diagnostics launches BREASTEST Monitor—blood test to monitor post-treatment breast cancer recurrence; 91% sensitivity, ...

Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in patients with high-risk resected melanoma over 5 years. The personalized mRNA therapy targets ...

This study aimed to develop a machine learning–based model to predict recurrence risk after perianal abscess surgery, thereby supporting personalized follow-up and intervention strategies. Clinical ...

Management of recoarctation in children is often dictated by age and anatomical complexity. Therapeutic interventions include balloon angioplasty, transcatheter stent implantation, and less commonly, ...

Survival outcomes of whole pelvic vs. bladder-only radiation in muscle-invasive bladder cancer: A nationwide large-scale study. Cumulative incidence rates by type of recurrences (N = 5,490) 1. 1 ...

In this retrospective study, 420 patients with pathologically confirmed breast cancer were included, randomly divided into training (70%) and test (30%) sets, with an independent external validation ...